Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
Edexlive on MSN

New cfDNA patent could scale early-stage cancer diagnosis in India

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Reliance’s Strand Life Sciences gets patent for blood-based early cancer detection

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Reliance’s Strand Life Sciences secures Indian patent for liquid biopsy platform

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...
Asianet Newsable on MSN

Reliance's Strand Life Sciences patents blood test for early cancer

Reliance's Strand Life Sciences has been granted an Indian patent for its platform enabling early cancer detection from a ...
dailyguidenetwork

Military Hospital Receives HIV Tester

The Chief of the Naval Staff (CNS) and Chairman of 37 Military Hospital Advisory Board, Rear Admiral Godwin Livinus Bessing, has received a newly installed COBAS 5800 Viral Load Machine on behalf of ...
psuconnect

Reliance’s Strand Life Sciences Secures Landmark Indian Patent for Blood-based Early Cancer Detection Technology

Strand Life Sciences, a subsidiary of Reliance Industries Limited, today announced the grant of an Indian patent covering its integrated platform for early cancer detection using cell-free DNA (cfDNA) ...